Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation)

Catalog No:
ATL-HPA055889-25
$360.00
Application: ICC, IHC 
Clonality: Polyclonal 
Host: Rabbit 
Reactivity: Human 
Protein Description: nuclear factor, erythroid 2-like 3
Gene Name: NFE2L3
Alternative Gene Name: Nrf3
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000029832: 67%, ENSRNOG00000010886: 58%
Entrez Gene ID: 9603
Uniprot ID: Q9Y4A8
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Cognate Antibody/Antigen for Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation)
Antigen PrEST Antigen NFE2L3 (ATL-APrEST86541)
Documents & Links for Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation)
Datasheet Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) at Atlas

Documents & Links for Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation)
Datasheet Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation)

Citations for Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) – 5 Found
RCAN1-4 is a thyroid cancer growth and metastasis suppressor.
JCI Insight. 2017 Mar 9;2(5):e90651. doi: 10.1172/jci.insight.90651.  PubMed
MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3.
Front Oncol. 2021 Dec 1;11:677168. doi: 10.3389/fonc.2021.677168. eCollection 2021.  PubMed
NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma.
Oxid Med Cell Longev. 2022 Mar 26;2022:2240223. doi: 10.1155/2022/2240223. eCollection 2022.  PubMed
Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients.
Cell Cycle. 2018;17(17):2164-2174. doi: 10.1080/15384101.2018.1520558. Epub 2018 Sep 22.  PubMed
Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor Suppressors.
Cancers (Basel). 2020 Sep 20;12(9):2681. doi: 10.3390/cancers12092681.  PubMed